Journal of Clinical Oncology, Vol 15, 1761-1766, Copyright © 1997 by American Society of Clinical Oncology
Endoscopic ultrasound in the evaluation of gastric small lymphocytic mucosa-associated lymphoid tumors
AC Pavlick, H Gerdes and CS Portlock
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
PURPOSE: Low-grade, small lymphocytic lymphomas of the mucosa- associated
lymphoid tissue (MALT) have recently been shown to be associated with
Helicobacter pylori infections. Regression of these tumors has been
reported with antibiotic therapy. Here we evaluate endoscopic ultrasound
(EUS) as on objective method to evaluate pretreatment disease and
posttherapy response. MATERIALS AND METHODS: We retrospectively reviewed 20
patients initially diagnosed elsewhere with MALT lymphoma. All patients had
their initial endoscopic biopsies (EGDs) reviewed at Memorial
Sloan-Kettering Cancer Center (MSKCC). All patients had EUS performed at
the time of consultation and on completion of therapy if treated at our
center. Antral biopsies were stained with a modified Steiner preparation to
determine infection by H pylori. RESULTS: Gastric low-grade lymphoma was
confirmed in 16 of 20 patients; 11 of 16 had previously received antibiotic
therapy for biopsy-positive H pylori infection. All gastric lymphomas had
an abnormal EUS: eight with discrete tumor masses and eight with gastric
wall infiltration (submucosa, n = 4; muscularis propria, n = 3; serosa, n =
1). On completion of lymphoma treatment with chemotherapy, radiotherapy, or
surgery, 11 of 16 patients underwent follow-up EUS. Five patients received
care elsewhere and did not return for posttreatment EUS. The gastric wall
was normal with no evidence of disease on EUS-guided biopsy in eight of 11
patients. The remaining three patients had abnormal gastric walls. One was
biopsy-negative and two had residual lymphoma. Four patients were found to
have benign lymphoid aggregates in association with H pylori on initial EGD
and EUS biopsies. All four patients were previously untreated with
antibiotics. EUS showed prominent mucosa, but no significant findings
within the gastric wall. CONCLUSION: EUS appears useful to stage
objectively and evaluate therapeutic outcome in the management of gastric,
low-grade MALT lymphomas. It also helps to distinguish benign lymphoid
aggregates from lymphoma associated with H pylori infection. EUS findings
may have a significant impact on assessment and therapeutic
recommendations.
This article has been cited by other articles:

|
 |

|
 |
 
F Di Raimondo, L Caruso, G Bonanno, P Naso, A Chiarenza, P Fiumara, A Bari, G. Palumbo, A Russo, and R Giustolisi
Is endoscopic ultrasound clinically useful for follow-up of gastric lymphoma?
Ann. Onc.,
February 1, 2007;
18(2):
351 - 356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Puspok, M Raderer, A Chott, B Dragosics, A Gangl, and R Schofl
Endoscopic ultrasound in the follow up and response assessment of patients with primary gastric lymphoma
Gut,
November 1, 2002;
51(5):
691 - 694.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Nakamura, T Matsumoto, H Suekane, M Takeshita, K Hizawa, M Kawasaki, T Yao, M Tsuneyoshi, M Iida, and M Fujishima
Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori
Gut,
April 1, 2001;
48(4):
454 - 460.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Cavalli, P. G. Isaacson, R. D. Gascoyne, and E. Zucca
MALT Lymphomas
Hematology,
January 1, 2001;
2001(1):
241 - 258.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Zucca, F. Bertoni, E. Roggero, and F. Cavalli
The gastric marginal zone B-cell lymphoma of MALT type
Blood,
July 15, 2000;
96(2):
410 - 419.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Raderer, J. Valencak, F. Pfeffel, J. Drach, T. Pangerl, A. Kurtaran, M. Hejna, F. Vorbeck, A. Chott, and I. Virgolini
Somatostatin Receptor Expression in Primary Gastric Versus Nongastric Extranodal B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue Type
J Natl Cancer Inst,
April 21, 1999;
91(8):
716 - 718.
[Full Text]
[PDF]
|
 |
|
|